Point-of-Care Medical Tests Devices and their Value as Educational Projects for Engineering Students

Mauk, Michael G.; Chiou, Richard; Carr, M. Eric; Gillander, Justin Bryan; Newton, Joshua C.; Reid, Kelly

doi:10.18260/1-2--22920

Cited by 1 publication

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Reduced reagent use of microfluidics is beneficial in areas with scarce resources, such as disease detection at the point of care (POC), and when very small amounts of samples are available on demand. POC diagnostic testing devices are disease detection (testing) devices that can be integrated at or near the point of care, that is, at the time and place of patient care [ 49 ]. Microfluidic chips can function as standalone biosensing devices or can be integrated with other biosensing setups to make them more like POC devices [ 50 ].…”

Section: Point-of-care (Poct) Assays For Infectious Diseasesmentioning

confidence: 99%

Nanotechnology-Based Diagnostics for Diseases Prevalent in Developing Countries: Current Advances in Point-of-Care Tests

et al. 2023

View full text Add to dashboard Cite

The introduction of point-of-care testing (POCT) has revolutionized medical testing by allowing for simple tests to be conducted near the patient’s care point, rather than being confined to a medical laboratory. This has been especially beneficial for developing countries with limited infrastructure, where testing often involves sending specimens off-site and waiting for hours or days for results. However, the development of POCT devices has been challenging, with simplicity, accuracy, and cost-effectiveness being key factors in making these tests feasible. Nanotechnology has played a crucial role in achieving this goal, by not only making the tests possible but also masking their complexity. In this article, recent developments in POCT devices that benefit from nanotechnology are discussed. Microfluidics and lab-on-a-chip technologies are highlighted as major drivers of point-of-care testing, particularly in infectious disease diagnosis. These technologies enable various bioassays to be used at the point of care. The article also addresses the challenges faced by these technological advances and interesting future trends. The benefits of point-of-care testing are significant, especially in developing countries where medical care is shifting towards prevention, early detection, and managing chronic conditions. Infectious disease tests at the point of care in low-income countries can lead to prompt treatment, preventing infections from spreading.

show abstract

Section: Point-of-care (Poct) Assays For Infectious Diseasesmentioning

confidence: 99%